Earnings Call · Q4 FY2023·2024-03-05

Q4 23EPS -61.15%·Rev n/aQ3 23EPS +41.86%·Rev n/aQ2 23EPS +9.28%·Rev n/aQ1 23EPS +39.13%·Rev n/a⚠ consensus missing

Nuwellis, Inc. NUWE

Vivian Cervantes — Investor Relations

Nestor Jaramillo — Chief Executive Officer

John Jefferies — Medical or Clinical Expert

Rob Scott — Chief Financial Officer

−6.0%1d on move date−6.5% vs SPY3d−2.0%5d−6.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NUWE calls or request research access.

More NUWE calls Browse calls Request research access